Literature DB >> 24813609

Impact of circadian nuclear receptor REV-ERBα on midbrain dopamine production and mood regulation.

Sooyoung Chung1, Eun Jeong Lee1, Seongsik Yun1, Han Kyoung Choe1, Seong-Beom Park2, Hyo Jin Son3, Kwang-Soo Kim4, Dean E Dluzen5, Inah Lee2, Onyou Hwang3, Gi Hoon Son6, Kyungjin Kim7.   

Abstract

The circadian nature of mood and its dysfunction in affective disorders is well recognized, but the underlying molecular mechanisms are still unclear. Here, we show that the circadian nuclear receptor REV-ERBα, which is associated with bipolar disorder, impacts midbrain dopamine production and mood-related behavior in mice. Genetic deletion of the Rev-erbα gene or pharmacological inhibition of REV-ERBα activity in the ventral midbrain induced mania-like behavior in association with a central hyperdopaminergic state. Also, REV-ERBα repressed tyrosine hydroxylase (TH) gene transcription via competition with nuclear receptor-related 1 protein (NURR1), another nuclear receptor crucial for dopaminergic neuronal function, thereby driving circadian TH expression through a target-dependent antagonistic mechanism. In conclusion, we identified a molecular connection between the circadian timing system and mood regulation, suggesting that REV-ERBα could be targeting in the treatment of circadian rhythm-related affective disorders.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24813609     DOI: 10.1016/j.cell.2014.03.039

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  117 in total

Review 1.  Mood-related central and peripheral clocks.

Authors:  Kyle D Ketchesin; Darius Becker-Krail; Colleen A McClung
Journal:  Eur J Neurosci       Date:  2018-11-29       Impact factor: 3.386

Review 2.  Circadian clock genes: effects on dopamine, reward and addiction.

Authors:  Puja K Parekh; Angela R Ozburn; Colleen A McClung
Journal:  Alcohol       Date:  2015-01-08       Impact factor: 2.405

Review 3.  Nuclear receptor Rev-erbα: up, down, and all around.

Authors:  Logan J Everett; Mitchell A Lazar
Journal:  Trends Endocrinol Metab       Date:  2014-07-22       Impact factor: 12.015

Review 4.  Circadian Rhythms and Substance Abuse: Chronobiological Considerations for the Treatment of Addiction.

Authors:  Ian C Webb
Journal:  Curr Psychiatry Rep       Date:  2017-02       Impact factor: 5.285

Review 5.  Emerging relevance of circadian rhythms in headaches and neuropathic pain.

Authors:  Mark J Burish; Zheng Chen; Seung-Hee Yoo
Journal:  Acta Physiol (Oxf)       Date:  2018-07-25       Impact factor: 6.311

Review 6.  Circadian regulation of membrane physiology in neural oscillators throughout the brain.

Authors:  Jodi R Paul; Jennifer A Davis; Lacy K Goode; Bryan K Becker; Allison Fusilier; Aidan Meador-Woodruff; Karen L Gamble
Journal:  Eur J Neurosci       Date:  2019-01-29       Impact factor: 3.386

7.  The circadian gene Nr1d1 in the mouse nucleus accumbens modulates sociability and anxiety-related behaviour.

Authors:  Changjiu Zhao; Stephen C Gammie
Journal:  Eur J Neurosci       Date:  2018-08-07       Impact factor: 3.386

Review 8.  The role of sleep problems and circadian clock genes in attention-deficit hyperactivity disorder and mood disorders during childhood and adolescence: an update.

Authors:  Alexander Dueck; Christoph Berger; Katharina Wunsch; Johannes Thome; Stefan Cohrs; Olaf Reis; Frank Haessler
Journal:  J Neural Transm (Vienna)       Date:  2015-10-15       Impact factor: 3.575

9.  The efficacy of (+)-Naltrexone on alcohol preference and seeking behaviour is dependent on light-cycle.

Authors:  Jonathan Henry W Jacobsen; Femke T A Buisman-Pijlman; Sanam Mustafa; Kenner C Rice; Mark R Hutchinson
Journal:  Brain Behav Immun       Date:  2017-08-30       Impact factor: 7.217

10.  Involvement of Nuclear Receptor REV-ERBβ in Formation of Neurites and Proliferation of Cultured Adult Neural Stem Cells.

Authors:  Koji Shimozaki
Journal:  Cell Mol Neurobiol       Date:  2018-02-03       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.